Can DeepScribe Be Used With NextGen?

DeepScribe does not say, beyond the outcomes, so this section is about what the options are and what to ask.

NextGen publishes an API Developer Program with three tracks. Patient Access APIs are free and cover patient facing data. The Open Access track is for a NextGen client building for its own use, with no fee stated. The API Distributor Program is the commercial track, with sandboxes and language that fees "may have associated fees based on the scope of data needs and/or other requirements". A scribe that reads problems, medications and labs and writes notes back needs broad scope, so it belongs on the Distributor track. Vendors on that track are generally listed on the marketplace; DeepScribe is not, which is the first question to put to them: which track, since when, and is a NextGen fee in our quote?

The second architectural question is standards. NextGen documents FHIR R4 and SMART App Launch for certified access, and its proprietary enterprise APIs for deeper operations. Reading chart context is plausible over FHIR. Writing a note into discrete NextGen template fields usually is not, and would rely on the proprietary APIs or on an HL7 v2 document interface through NextGen Connect, the engine formerly called Mirth. Ask which. If the answer involves NextGen Connect, somebody in your organisation owns that interface, and you should know who before you sign.

The third is the client. DeepScribe captures on a mobile app and the clinician reviews in DeepScribe's own interface; the NextGen schedule sync exists so the clinician does not have to retype the patient. That is not a SMART launch inside the NextGen chart. It works, and it is a second application on the clinician's phone. Our EHR integration questions post sets out the full list in the order to ask them.

Per DeepScribe, three things. Before the visit, it pulls the schedule and chart context so the note reflects known problems and medications rather than only what was said. During the visit, it records ambiently on the clinician's device. After the visit, it produces a specialty specific note and writes structured elements into NextGen fields rather than pasting a single block of text.

The specialty claim is the substantive one. DeepScribe states its models are trained on specialty encounters in the six specialties named above and that its integration and specialty coverage align with NextGen's customer base. That is a testable claim: ask for a sample note in your specialty produced from a NextGen practice, and pilot with your most complex visit types rather than your simplest.

Two numbers appear in DeepScribe's material and need handling. A KLAS Spotlight score of 98.8 out of 100 is a real third party measure, but a Spotlight report is commissioned and based on a vendor supplied customer list; read the report's sample size before quoting the score to your board. Any time saving figure should be measured against your own baseline. The ROI calculator exposes its assumptions for exactly that purpose. What the write back looks like field by field is not published. Not published. Checked September 2026. Get the field map in writing and see it on your own NextGen templates.

• Business associate agreement with DeepScribe, covering audio and transcript storage location, retention, whether your data trains shared models, and subprocessors.
• NextGen access. Which developer track, which APIs, which scopes, and whether a NextGen fee applies. If an HL7 interface is involved, who builds and maintains it.
• Write back safety. Whether notes land as drafts or signed, whether discrete data such as problems or medications is written automatically or only on clinician acceptance, and what the audit trail shows.
• Device policy. Capture is on a phone; your mobile device management, screen lock and lost device procedures now cover recorded encounters.
• Coding. If the note suggests diagnosis or procedure codes, your compliance officer needs a documented review step. This is the same point we make about NextGen's own Ambient Assist, which NextGen says supports diagnostic and order codes.
• Marketplace status. Because there is no NextGen validated listing, document your own validation: what you tested, on which NextGen version, with what result.

The HIPAA and AI compliance page has the vendor questions in order, and the HIPAA compliant AI scribe checklist is built for this exact procurement.

Evidence is the first gap. A vendor blog post is the only public source for the NextGen integration as of September 2026. Ask for two NextGen Enterprise practices in your specialty, live for more than six months, and call them about write back reliability rather than note quality.

NextGen Office is the second. Nothing DeepScribe publishes distinguishes NextGen Enterprise from NextGen Office, and the two have different API surfaces. If you run Office, ask directly.

Pricing is the third. DeepScribe quotes on request. Not published. Checked September 2026. Ask for per clinician pricing, minimum term, implementation fees and whether any NextGen API charge is passed through. DeepScribe pricing covers what can be established in advance.

The fourth is the bundle. NextGen Ambient Assist is already integrated, already supported by your EHR vendor and already on the NextGen Mobile app your clinicians carry. DeepScribe has to be measurably better in your specialty to justify a second vendor, a second BAA and a second application. That is a fair test and DeepScribe may pass it; run it rather than assuming either way. The scribe comparison sets out how the vendors line up on integration evidence.

• Which NextGen developer track is DeepScribe on, since when, and does a NextGen fee apply to us?
• Which NextGen product and version is the integration live on, Enterprise or Office?
• Which NextGen template sections and discrete fields does the note populate, and is it draft or signed?
• Does any part of the integration depend on an HL7 interface through NextGen Connect, and who maintains it?
• Show us the schedule sync and the write back on our own NextGen build, in our specialty templates.
• What is the sample size behind the KLAS Spotlight score?
• Which two NextGen practices in our specialty can we call?
• Per clinician price, minimum term, implementation fee and renewal cap?

The ambient scribe use case page explains how to structure a thirty day pilot against NextGen Ambient Assist so the comparison is on your encounters, not on demos.

This pairing is a judgement call with incomplete public evidence. DeepScribe describes a deep integration and has real specialty strength; NextGen has a bundled alternative with no integration risk at all; and the only way to resolve it is to test both on your encounters and check DeepScribe's NextGen claims against a working build and live references. Neither vendor will do that for you.

Our vendor selection engagement runs the head to head, verifies the developer track, field map and references in writing, and gives your group a documented decision. If you are earlier than that and want to know whether your sites and interfaces are ready for any scribe, the AI readiness audit answers that first. We take no commissions from DeepScribe, NextGen or anyone else. Book a call.